Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial.
Type de publicationJournal Article
Year of Publication2014
AuteursTredaniel J, Barlesi F, Le Pechoux C, Lerouge D, Pichon E, Le Moulec S, Moreau L, Friard S, Westeel V, Petit L, Carre O, Guichard F, Raffy O, Villa J, Prevost A, Lebitasy MPaule, Morin F, Zalcman G, Mornex F, IFCT FIntergrp T
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume32
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X